RESEARCHER PROFILE
Associate Professor Tasha Stanton, (Filmed May 2024)
Associate Professor of Clinical Pain Neuroscience
SAHMRI (South Australian Health and Medical Research Institute) & University of South Australia, Adelaide, South Australia
Associate Professor Tasha Stanton leads the Persistent Pain Research Group at SAHMRI. She is also co-Director of IIMPACT in Health at the University of South Australia, Adelaide. She is a clinical pain neuroscientist, with original training as a physiotherapist, and her research focusses on pain – why do we have it and why doesn’t it go away? She has received over $7.3m in competitive research funding, including fellowships from the Canadian Institute for Health Research and the National Health & Medical Research Council (Early Career Fellowship, Career Development Fellowship), has published >110 peer-reviewed journal articles, and she has been a keynote/invited speaker at >100 national and international conferences. Her research has won both national and international awards, including the World Congress of Pain Ronald Dubner Research Prize, the Australian Pain Society Rising Star Award and the Australian Physiotherapy Association Best New Investigator Award.
Her research explores the sensory and cognitive contributors to pain and spans discovery to clinical implementation. That is, her work aims to better understand how the experience of pain is created and to use this knowledge to develop and test novel brain-based treatments for pain. She investigates the sensory contributors (and neural underpinnings) of pain in a unique way – by manipulating our sense of reality. Using mediated and virtual reality, her work explores the contribution of multisensory input to the experience of pain and to the experiences of (and engagement in) effortful treatments such as exercise. She is also interested in the role that pain science education – specifically shifting how an individual conceptualises and understands pain – plays in recovery from chronic pain, with a focus on knee osteoarthritis. She has authored a book (EPIPHAKNEE) that provides contemporary pain science knowledge about osteoarthritis and its treatment for both people with osteoarthritis and their treating clinicians.
Tasha holds active roles in knowledge dissemination, science communication, and media engagement. She was recognised as one of Australia’s Top 5 under 40 Science Communicators (ABC Radio National and UNSW) and was the SA Tall Poppy of the Year in 2015. She is the founder of the Brain Bus – a mobile experiential lab that promotes knowledge transfer via real-world experiences. Through Pain Revolution (educational tour) – The Brain Bus has reached >5k people in rural and regional Australia. She has been featured on ABC’s Weekender, All in the Mind, Health Report, Catalyst, and Conversations with Sarah Kanowski.
You Might also like
-
Podiatric Research In Children, the workforce and the LGBTQIA+ community
Professor Williams holds the role of Deputy Head of School, School of Primary and Allied Health Care, and course coordinator of the Doctor of Podiatric Medicine degree. She is a podiatrist, and has held professional roles in community health, acute and subacute services in child health care teams, research leadership and professional governance.
-
Stem cells used for age-related macular degeneration
Dr. Jenna Hall is a passionate and accomplished biologist with expertise in induced pluripotent stem cell (iPSC) culture, disease modelling, and high-throughput automated systems. She recently earned her PhD from the University of Melbourne, where her research focused on using iPSC-derived retinal pigment epithelium (RPE) cells to study age-related macular degeneration. Dr Hall’s technical skillset spans manual and automated cell reprogramming and differentiation, quantitative microscopy-based phenotyping, and large scale -omics analysis.
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.